Timothy Power | VP & Head, IR |
Giovanni Caforio | Chairman & CEO |
David Elkins | EVP & CFO |
Christopher Boerner | EVP & Chief Commercialization Officer |
Samit Hirawat | EVP & Chief Medical Officer, Global Drug Development |
Geoffrey Meacham | Bank of America |
Chris Shibutani | Goldman Sachs |
Christopher Schott | JPMorgan |
Seamus Fernandez | Guggenheim Securities |
Stephen Scala | Cowen and Company |
Timothy Anderson | Wolfe Research |
Evan Seigerman | BMO Capital Markets |
Terence Flynn | Morgan Stanley |
Mohit Bansal | Wells Fargo |
Carter Gould | Barclays |
Matthew Phipps | William Blair |
Robyn Karnauskas | Truist Securities |
Olivia Brayer | Cantor Fitzgerald |
Andrew Baum | Citigroup |
Colin Bristow | UBS |
Good morning. My name is Dennis, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bristol-Myers Squibb Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference over to Tim Power, Vice President of Investor Relations.